Waters Corporation (NYSE:WAT) Stock Has Consensus Price Target of $475.48

Waters logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst sentiment is broadly positive: Waters has a “Moderate Buy” consensus from 24 brokerages—17 buys, six holds and one strong buy—with an average 12-month price target of $475.48.
  • Recent quarterly results topped estimates: Waters reported EPS of $4.10 versus $4.00 expected and revenue of $1.77 billion versus $1.75 billion expected; revenue rose 120.9% year over year.
  • Several analysts raised their price targets, including Barclays to $530 and Goldman Sachs to $515. Shares opened at $449.28, within the stock’s 12-month range of $282.77 to $483.33.
  • MarketBeat previews the top five stocks to own by December 1st.

Waters Corporation (NYSE:WAT - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty-four brokerages that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $475.48.

Several equities analysts recently weighed in on the stock. Barclays increased their price objective on shares of Waters from $500.00 to $530.00 and gave the company an "overweight" rating in a report on Wednesday, November 4th. HSBC lifted their target price on shares of Waters from $450.00 to $455.00 and gave the stock a "buy" rating in a report on Tuesday, September 1st. The Goldman Sachs Group increased their target price on Waters from $465.00 to $515.00 and gave the company a "buy" rating in a research note on Monday, September 21st. Guggenheim boosted their target price on Waters from $440.00 to $490.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Finally, Evercore increased their price target on shares of Waters from $410.00 to $480.00 in a research report on Wednesday, October 7th.

Get Our Latest Research Report on Waters

Waters Price Performance

Shares of WAT stock opened at $449.28 on Wednesday. The firm has a market cap of $44.16 billion, a price-to-earnings ratio of 192.82, a PEG ratio of 2.58 and a beta of 1.16. Waters has a 12 month low of $282.77 and a 12 month high of $483.33. The company has a quick ratio of 1.28, a current ratio of 1.89 and a debt-to-equity ratio of 0.29. The stock has a 50-day moving average price of $442.24 and a 200 day moving average price of $374.83.

Waters (NYSE:WAT - Get Free Report) last released its earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.75 billion. During the same period in the prior year, the company posted $3.40 EPS. The company's revenue was up 120.9% compared to the same quarter last year. Research analysts expect that Waters will post 14.65 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. California Public Employees Retirement System grew its position in Waters by 25.4% during the first quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier's stock worth $41,222,000 after buying an additional 28,074 shares in the last quarter. Dudley & Shanley Inc. lifted its holdings in shares of Waters by 101.3% during the 2nd quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier's stock worth $8,847,000 after acquiring an additional 11,870 shares during the period. Handelsbanken Fonder AB boosted its position in shares of Waters by 93.1% during the 2nd quarter. Handelsbanken Fonder AB now owns 93,653 shares of the medical instruments supplier's stock worth $35,124,000 after acquiring an additional 45,145 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its position in shares of Waters by 18.4% during the 2nd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 95,028 shares of the medical instruments supplier's stock worth $35,639,000 after acquiring an additional 14,754 shares in the last quarter. Finally, Hikari Power Ltd bought a new position in Waters in the second quarter valued at approximately $1,793,000. Institutional investors and hedge funds own 94.01% of the company's stock.

About Waters

(Get Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

See Also

Analyst Recommendations for Waters (NYSE:WAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines